{"id":310,"date":"2014-03-14T13:14:06","date_gmt":"2014-03-14T11:14:06","guid":{"rendered":"https:\/\/mic-site.labiux.com\/uncategorized\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/"},"modified":"2026-10-06T06:29:24","modified_gmt":"2026-10-06T03:29:24","slug":"konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/","title":{"rendered":"Konkurences padome pie\u013cauj &#8211; da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p><b><\/b>Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.<\/p>\n<p>\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes paudusi Konkurences padome (KP). P\u0113t\u012bjuma ietvaros KP apl\u016bkoja tirgus strukt\u016bru un tendences, k\u0101 ar\u012b izv\u0113rt\u0113ja cenu noteik\u0161anu ietekm\u0113jo\u0161os faktorus, ori\u0123in\u0101lo un \u0123en\u0113risko jeb patentbr\u012bvo z\u0101\u013cu pieejam\u012bbu.<\/p>\n<p>Lai noskaidrotu, vai jaunu \u0123en\u0113risko z\u0101\u013cu pied\u0101v\u0101jums ietekm\u0113 cenas tirg\u016b, KP veica medikamenta atorvastat\u012bna cenu izmai\u0146u anal\u012bzi. Izp\u0113te \u013c\u0101vusi secin\u0101t, ka p\u0113c ori\u0123in\u0101lo z\u0101\u013cu &#8220;Sortis&#8221; patentaizsardz\u012bbas beig\u0101m tirg\u016b strauji ien\u0101ku\u0161i vair\u0101ki \u0123en\u0113risko z\u0101\u013cu ra\u017eot\u0101ji &#8211; Eirop\u0101 to ir vair\u0101k nek\u0101 desmit, un devi\u0146i no tiem ir p\u0101rst\u0101v\u0113ti Latvij\u0101. Lai ar\u012b \u0161\u0137\u0113r\u0161\u013ci atorvastat\u012bna ra\u017eo\u0161anas uzs\u0101k\u0161anai Latvij\u0101 netika konstat\u0113ti, valst\u012b \u0161\u012bs z\u0101les nera\u017eo, sav\u0101 pazi\u0146ojum\u0101 presei nor\u0101da KP.<\/p>\n<p>Uz\u0146\u0113mumiem, kas v\u0113las uzs\u0101kt sirds un asinsvadu slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu ra\u017eo\u0161anu vai tirdzniec\u012bbu, j\u0101r\u0113\u0137in\u0101s ar z\u0101\u013cu ra\u017eo\u0161anas un izplat\u012b\u0161anas tirgiem rakstur\u012bgaj\u0101m administrat\u012bvaj\u0101m un finansi\u0101laj\u0101m barjer\u0101m, kas saist\u012btas ar re\u0123istr\u0101cijas un p\u0101rre\u0123istr\u0101cijas maks\u0101jumiem, ra\u017eo\u0161anas uzs\u0101k\u0161anas un z\u0101\u013cu izplat\u012b\u0161anas izdevumiem.<\/p>\n<p>Latvij\u0101 pieejamo atorvastat\u012bna \u0123en\u0113risko z\u0101\u013cu cenas jau s\u0101kotn\u0113ji biju\u0161as vismaz uz pusi l\u0113t\u0101kas par ori\u0123in\u0101lo z\u0101\u013cu cen\u0101m, un t\u0101 ietekm\u0113 aptiek\u0101s samazin\u0101ju\u0161\u0101s ar\u012b &#8220;Sortis&#8221; cenas. Vienlaikus cenu samazin\u0101jumu ietekm\u0113jis ar\u012b konkurences spiediens \u0123en\u0113risko z\u0101\u013cu ra\u017eot\u0101ju vid\u016b. Uz\u0146\u0113mumi, kas laika posm\u0101 no 2011. l\u012bdz 2013.gadam uzs\u0101ku\u0161i atorvastat\u012bna ra\u017eo\u0161anu, savus p\u0101rdo\u0161anas apjomus Latvij\u0101 palielin\u0101ju\u0161i uz citu liel\u0101ko \u0123en\u0113risko un ori\u0123in\u0101lo z\u0101\u013cu ra\u017eot\u0101ju p\u0101rdo\u0161anas apjoma r\u0113\u0137ina. T\u0101d\u0113j\u0101di secin\u0101ms, ka tirg\u016b notikusi konkurences c\u012b\u0146a un pat\u0113r\u0113t\u0101ji main\u012bju\u0161i savu izv\u0113li atkar\u012bb\u0101 no pied\u0101v\u0101juma, pazi\u0146ojum\u0101 masu medijiem nor\u0101da KP.<\/p>\n<p>El\u012bna Badune<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11830,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[70,76,73],"tags":[],"mic_flag":[],"class_list":["post-310","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farmacijas-zinas","category-jaunakie-raksti","category-medikamentu-zinas"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t\t<meta property=\"og:image:height\" content=\"224\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2014-03-14T11:14:06+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-10-06T03:29:24+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"position\":2,\"name\":\"Farm\\u0101cija\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#listItem\",\"name\":\"Konkurences padome pie\\u013cauj &#8211; da\\u013cai ra\\u017eot\\u0101ju z\\u0101\\u013cu izplat\\u012b\\u0161ana Latvij\\u0101 var k\\u013c\\u016bt nerentabla\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#listItem\",\"position\":3,\"name\":\"Konkurences padome pie\\u013cauj &#8211; da\\u013cai ra\\u017eot\\u0101ju z\\u0101\\u013cu izplat\\u012b\\u0161ana Latvij\\u0101 var k\\u013c\\u016bt nerentabla\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/farmacijas-zinas\\\/#listItem\",\"name\":\"Farm\\u0101cija\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#newsarticle\",\"name\":\"Konkurences padome pie\\u013cauj \\u2013 da\\u013cai ra\\u017eot\\u0101ju z\\u0101\\u013cu izplat\\u012b\\u0161ana Latvij\\u0101 var k\\u013c\\u016bt nerentabla - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Konkurences padome pie\\u013cauj &#8211; da\\u013cai ra\\u017eot\\u0101ju z\\u0101\\u013cu izplat\\u012b\\u0161ana Latvij\\u0101 var k\\u013c\\u016bt nerentabla\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg\",\"width\":400,\"height\":224},\"datePublished\":\"2014-03-14T13:14:06+02:00\",\"dateModified\":\"2026-10-06T06:29:24+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#webpage\"},\"articleSection\":\"Farm\\u0101cija, Jaun\\u0101kie raksti, Medikamenti\",\"dateline\":\"Published on March 14, 2014.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/\",\"name\":\"Konkurences padome pie\\u013cauj \\u2013 da\\u013cai ra\\u017eot\\u0101ju z\\u0101\\u013cu izplat\\u012b\\u0161ana Latvij\\u0101 var k\\u013c\\u016bt nerentabla - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Kopum\\u0101 sirds un asinsrites sist\\u0113mu slim\\u012bb\\u0101m paredz\\u0113to z\\u0101\\u013cu ra\\u017eot\\u0101ju vid\\u016b past\\u0101v sp\\u0113c\\u012bga konkurence un nav v\\u0113rojama liela tirgus dal\\u012bbnieku main\\u012bba, ta\\u010du, \\u0146emot v\\u0113r\\u0101 administrat\\u012bv\\u0101s izmaksas, kas Latvij\\u0101 ir vienas no augst\\u0101kaj\\u0101m Eirop\\u0101, k\\u0101 ar\\u012b nelielo tirgu, n\\u0101kotn\\u0113 da\\u013cai ra\\u017eot\\u0101ju z\\u0101\\u013cu izplat\\u012b\\u0161ana Latvij\\u0101 var k\\u013c\\u016bt nerentabla.\\u0160\\u0101dus secin\\u0101jumus p\\u0113c asinsrites sist\\u0113mas slim\\u012bbu \\u0101rst\\u0113\\u0161anai paredz\\u0113to z\\u0101\\u013cu tirgus izp\\u0113tes\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#mainImage\",\"width\":400,\"height\":224},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\\\/#mainImage\"},\"datePublished\":\"2014-03-14T13:14:06+02:00\",\"dateModified\":\"2026-10-06T06:29:24+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs","description":"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes","canonical_url":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","position":2,"name":"Farm\u0101cija","item":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#listItem","name":"Konkurences padome pie\u013cauj &#8211; da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#listItem","position":3,"name":"Konkurences padome pie\u013cauj &#8211; da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/#listItem","name":"Farm\u0101cija"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#newsarticle","name":"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs","headline":"Konkurences padome pie\u013cauj &#8211; da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg","width":400,"height":224},"datePublished":"2014-03-14T13:14:06+02:00","dateModified":"2026-10-06T06:29:24+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#webpage"},"articleSection":"Farm\u0101cija, Jaun\u0101kie raksti, Medikamenti","dateline":"Published on March 14, 2014."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/","name":"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs","description":"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#mainImage","width":400,"height":224},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/#mainImage"},"datePublished":"2014-03-14T13:14:06+02:00","dateModified":"2026-10-06T06:29:24+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs","og:description":"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes","og:url":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg","og:image:width":400,"og:image:height":224,"article:published_time":"2014-03-14T11:14:06+00:00","article:modified_time":"2026-10-06T03:29:24+00:00","twitter:card":"summary_large_image","twitter:title":"Konkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla - Medikamentu Inform\u0101cijas Centrs","twitter:description":"Kopum\u0101 sirds un asinsrites sist\u0113mu slim\u012bb\u0101m paredz\u0113to z\u0101\u013cu ra\u017eot\u0101ju vid\u016b past\u0101v sp\u0113c\u012bga konkurence un nav v\u0113rojama liela tirgus dal\u012bbnieku main\u012bba, ta\u010du, \u0146emot v\u0113r\u0101 administrat\u012bv\u0101s izmaksas, kas Latvij\u0101 ir vienas no augst\u0101kaj\u0101m Eirop\u0101, k\u0101 ar\u012b nelielo tirgu, n\u0101kotn\u0113 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla.\u0160\u0101dus secin\u0101jumus p\u0113c asinsrites sist\u0113mas slim\u012bbu \u0101rst\u0113\u0161anai paredz\u0113to z\u0101\u013cu tirgus izp\u0113tes","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/stock-footage-technicians-inspecting-the-quality-of-pills-at-a-pharmaceutical-plant.jpg"},"aioseo_meta_data":{"post_id":"310","title":null,"description":null,"keywords":null,"keyphrases":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-09-22 18:28:34","updated":"2026-10-07 11:05:09"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/\" title=\"Farm\u0101cija\">Farm\u0101cija<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tKonkurences padome pie\u013cauj \u2013 da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Farm\u0101cija","link":"https:\/\/farmacija-mic.lv\/category\/farmacijas-zinas\/"},{"label":"Konkurences padome pie\u013cauj &#8211; da\u013cai ra\u017eot\u0101ju z\u0101\u013cu izplat\u012b\u0161ana Latvij\u0101 var k\u013c\u016bt nerentabla","link":"https:\/\/farmacija-mic.lv\/en\/konkurences-padome-pielauj-dalai-razotaju-zalu-izplatisana-latvija-var-klut-nerentabla\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/310","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=310"}],"version-history":[{"count":1,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/310\/revisions"}],"predecessor-version":[{"id":2042,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/310\/revisions\/2042"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/11830"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=310"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=310"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=310"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=310"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}